These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31473143)

  • 1. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets.
    Gentilin E; Simoni E; Candito M; Cazzador D; Astolfi L
    Trends Mol Med; 2019 Dec; 25(12):1123-1132. PubMed ID: 31473143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity.
    Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Pandit A; Shim H; Yang SH; Cho EY; Song J; Kwak TH; Choe SK; Park R; So HS
    Hear Res; 2015 Aug; 326():30-9. PubMed ID: 25891352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of autophagy in cisplatin-induced ototoxicity.
    Youn CK; Kim J; Park JH; Do NY; Cho SI
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1814-9. PubMed ID: 26307546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic Reticulum Stress Is Involved in Cochlear Cell Apoptosis in a Cisplatin-Induced Ototoxicity Rat Model.
    Zong S; Liu T; Wan F; Chen P; Luo P; Xiao H
    Audiol Neurootol; 2017; 22(3):160-168. PubMed ID: 29049998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress on the relationship between cisplatin ototoxicity and autophagy].
    Liang Z; Cheng G; Zhang T; Jia H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):189-192. PubMed ID: 32086932
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
    Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
    Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss.
    Sheth S; Sheehan K; Dhukhwa A; Al Aameri RFH; Mamillapalli C; Mukherjea D; Rybak LP; Ramkumar V
    Sci Rep; 2019 Jul; 9(1):9571. PubMed ID: 31267026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.
    Kim HJ; Oh GS; Shen A; Lee SB; Choe SK; Kwon KB; Lee S; Seo KS; Kwak TH; Park R; So HS
    Cell Death Dis; 2014 Jun; 5(6):e1292. PubMed ID: 24922076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
    Tan WJT; Vlajkovic SM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of cisplatin-induced ototoxicity and prevention.
    Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
    Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and restoration of hearing loss associated with the use of cisplatin.
    Chirtes F; Albu S
    Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-phycocyanin from
    Kim YR; Do JM; Kim KH; Stoica AR; Jo SW; Kim UK; Yoon HS
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Strategies to Combat Cisplatin-Induced Ototoxicity.
    Yu D; Gu J; Chen Y; Kang W; Wang X; Wu H
    Front Pharmacol; 2020; 11():999. PubMed ID: 32719605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
    Shin YS; Song SJ; Kang S; Hwang HS; Jung YS; Kim CH
    J Appl Toxicol; 2014 Feb; 34(2):191-204. PubMed ID: 23297007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
    Kros CJ; Steyger PS
    Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 30559254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
    Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
    Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.